Back to YC Companies
Rejuvenation Technologies Inc.
Summer 2018
Active
mRNA therapeutics to extend healthspan entering clinical trials
7 people View on YC
Rejuvenation Technologies Inc. at a glance
- Y Combinator batch
- Summer 2018
- Status
- Active
- Industry
- Healthcare
- Team size
- 7 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
Compare Rejuvenation Technologies Inc. with similar YC companies →
About Rejuvenation Technologies Inc.
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Reverses 10 years of telomere shortening with a single dose. Preclinical efficacy in fibrotic liver and lung disease. Entering IND-enabling. 50+ granted patents, 7 patent families. FDA INTERACT cleared.
Tags:
Anti-Aging
Gene Therapy
Nanomedicine